530313
KIMIABL
Start SIP
Invest Now
Start SIP in KIMIABL
Performance
- Low
- ₹31
- High
- ₹36
- 52 Week Low
- ₹26
- 52 Week High
- ₹87
- Open Price₹33
- Previous Close₹32
- Volume3,367
Investment Returns
- Over 1 Month + 4.1%
- Over 3 Month -9.47%
- Over 6 Month -32.25%
- Over 1 Year -33%
Smart Investing Starts Here Start SIP with Kimia Biosciences for Steady Growth!
Kimia Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 18.8
- PEG Ratio
- 0.1
- Market Cap Cr
- 154
- P/B Ratio
- Average True Range
- 2.61
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.09
- RSI
- 53.89
- MFI
- 15.01
Kimia Biosciences Financials
Kimia Biosciences Technicals
EMA & SMA
Current Price
₹32.52
+
0.26
(0.81%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹30.70
- 50 Day
- ₹33.18
- 100 Day
- ₹37.26
- 200 Day
- ₹41.28
Resistance and Support
31.91
- R3 38.88
- R2 36.44
- R1 34.35
- S1 29.82
- S2 27.38
- S3 25.29
Kimia Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-09-04 | Final Dividend & A.G.M. | |
| 2025-08-29 | A.G.M. & Others | Inter-alia, to consider 1. Appointment of Neeraj Arora & Associates, Chartered Accountants as Statutory Auditors for 5 years. 2. Re-appointment of Mr. Sameer Goel. 3. Other business matters. |
| 2025-08-14 | Quarterly Results | |
| 2025-05-26 | Audited Results |
Kimia Biosciences F&O
About Kimia Biosciences
- NSE Symbol
- KIMIABL
- BSE Symbol
- 530313
- Chairman & Managing Director
- Mr. Sameer Goel
- ISIN
- INE285U01025
Similar Stocks to Kimia Biosciences
Kimia Biosciences FAQs
Kimia Biosciences share price is ₹32 As on 11 December, 2025 | 11:13
The Market Cap of Kimia Biosciences is ₹153.9 Cr As on 11 December, 2025 | 11:13
The P/E ratio of Kimia Biosciences is 18.8 As on 11 December, 2025 | 11:13
The PB ratio of Kimia Biosciences is 15.4 As on 11 December, 2025 | 11:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.